METIS FOUNDATION
SAN ANTONIO, Texas
Total Received
$53.6M
Total Awards
34
State
Texas
Last Updated
Jan 28, 2026
Yearly Funding Trend
$36.7M24
$16.9M25
Top 34 Awards to METIS FOUNDATION
Largest individual federal awards on record for this recipient, ranked by obligated amount. Data through January 28, 2026.
| Award | Awarding Agency | Program | Place | FY | Obligation |
|---|---|---|---|---|---|
ASST_NON_HU00012520010_097 MILITARY CARDIOVASCULAR OUTCOMES RESEARCH (MICOR) CORE | Department of Defense Uniformed Services University of the Health Sciences | 12.750 UNIFORMED SERVICES UNIVERSITY MEDICAL RESEARCH PROJECTS | BETHESDA, MD-08 | 2025 | $5,567,288 |
ASST_NON_HU00012120008_097 MILITARY CARDIOVASCULAR OUTCOMES RESEARCH (MICOR) | Department of Defense Uniformed Services University of the Health Sciences | 12.750 UNIFORMED SERVICES UNIVERSITY MEDICAL RESEARCH PROJECTS | — | 2024 | $4,910,517 |
ASST_NON_W81XWH1920016_097 CELLULAR THERAPIES FOR THE TREATMENT OF ACUTE RADIATION SYNDROME COMBINED WITH TRAUMATIC INJURY THIS MODIF ICATION: 1. EXTENDS THE POP BY 6 MONTHS; THE FINAL TECHNICAL REPORT, W I… | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | SAN ANTONIO, TX-35 | 2024 | $4,606,031 |
ASST_NON_HU00012420066_097 MILITARY CARDIOVASCULAR OUTCOMES RESEARCH (MICOR) ELECTROCARDIOGRAM RISK ASSESSMENT TO PREVENT SUDDEN CARDIAC EVENTS (ERASE) PROGRAM | Department of Defense Uniformed Services University of the Health Sciences | 12.750 UNIFORMED SERVICES UNIVERSITY MEDICAL RESEARCH PROJECTS | — | 2024 | $2,700,213 |
ASST_NON_HU00012420018_097 MILITARY CARDIOVASCULAR OUTCOMES RESEARCH (MICOR)- FY24 CORE | Department of Defense Uniformed Services University of the Health Sciences | 12.750 UNIFORMED SERVICES UNIVERSITY MEDICAL RESEARCH PROJECTS | — | 2024 | $2,693,485 |
ASST_NON_HU00012320002_097 MILITARY CARDIOVASCULAR OUTCOMES RESEARCH (MICOR)-FY23 | Department of Defense Uniformed Services University of the Health Sciences | 12.750 UNIFORMED SERVICES UNIVERSITY MEDICAL RESEARCH PROJECTS | BETHESDA, MD-08 | 2024 | $2,672,051 |
ASST_NON_W81XWH1920052_097 THIS MODIFICATION: 1. EXTENDS THE POP BY 12 MONTHS. TECHNICAL AND FINANCIAL REPORTING SHALL CONTINUE IN ACCORDANCE WITH THE AWARD TERMS AND CONDITIONS. 2. UPDATES DIVISION I ITEMS… | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | SAN ANTONIO, TX-35 | 2024 | $2,449,953 |
CONT_AWD_W81XWH22C0143_9700_-NONE-_-NONE- PROPOSAL LOG NO. JW210408 - MAJ TASK 2&3 PROJECT TITLE: PHASE I CLINICAL TRIAL UTILIZING SN514 FOR ENZYMATIC DEBRIDEMENT OF BURNS | Department of Defense Defense Health Agency | — | SAN ANTONIO, TX-20 | 2024 | $2,433,591 |
ASST_NON_HT94252310574_097 A PROSPECTIVE STUDY USING SUPRASDRM IN PROMOTING HEALING AND REDUCING THE TIME TO GRAFTING OF FULL THICKNESS WOUNDS TO ACCELER ATE RETURN TO DUTY | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | SAN ANTONIO, TX-20 | 2025 | $2,199,210 |
ASST_NON_HT94252311074_097 ANTIBIOTIC CONCENTRATIONS AFTER MASSIVE TRANSFUSION (ACME) STUDY CHANGE OF PRINCIPAL INVESTIGATOR, REMOVE PAYMENT RESTRICTION CLAUSE, OHRO HUMAN USE APPROVED | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | SAN ANTONIO, TX-20 | 2025 | $2,198,183 |
ASST_NON_HT94252320029_097 IMPROVING SEVERE BURN RESUSCITATION OUTCOMES WITH ICATIBANT, AN FDA-APPROVED, SPECIFIC BRADYKININ B2 RECEPTOR ANTAGONIST EXTEND THE PERIOD OF PERFORMANCE | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | SAN ANTONIO, TX-20 | 2025 | $1,987,608 |
ASST_NON_W81XWH2120053_097 A NEW PARADIGM IN TRAUMA CARE: THE LETHAL TETRAD OF INJURY-INDUCED HYPOCALCEMIA, ACIDOSIS, COAGULOPATHY, AND HYPOTHERMIA. 1. EXTENDS THE POP BY 12 MONTHS. TECHNICAL AND FINANCIAL… | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | SAN ANTONIO, TX-20 | 2024 | $1,899,495 |
ASST_NON_HT94252411032_097 NOVEL THERAPEUTICS TARGET INNATE IMMUNE RESPONSES FOR TREATING MULTIPLE ORGAN FAILURE IN SEVERE POLYTRAUMA DURING PROLONGED CASUALTY CARE | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | SAN ANTONIO, TX-20 | 2024 | $1,845,076 |
ASST_NON_W81XWH2020038_097 AN AUTONOMOUS DYNAMIC SENSOR TECHNOLOGY FOR PATHOPHYSIOLOGICAL MONITORING AND RESUSCITATIVE GUIDANCE IN ACTIVE DENIAL ENVIRONMENTS. THIS MODIFICATION:1. EXTENDS THE POP BY 12 MONT… | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | SAN ANTONIO, TX-35 | 2024 | $1,600,654 |
ASST_NON_W81XWH2110852_097 SPERRY MICRO-CORING SYSTEM: AUTOMATED FULL THICKNESS SKIN MICROCOLUMNS IN DERMAL REGENERATION TEMPLATES FOR DONOR-FREE SKIN RENEWAL IN PROLONGED FIELD CARE EXTEND THE PERIOD OF PE… | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | SAN ANTONIO, TX-20 | 2024 | $1,499,939 |
ASST_NON_W81XWH2110557_097 SUPRATHEL USE DURING PROLONGED FIELD CARE TO PROMOTE HEALING AND REDUCE THE NEED FOR GRAFTING OF BURN WOUNDS EXTEND THE PERIOD OF PERFORMANCE 1. PER SECTION 711 OF THE NATIONAL DE… | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | SAN ANTONIO, TX-20 | 2024 | $1,499,440 |
ASST_NON_HT94252410367_097 PORTABLE INTEGRATED OPTIC BIOSENSORS FOR RECOGNIZING EARLY POTENTIAL LOSS OF AMPUTATED NATIVE TISSUE (REPLANT) IN RECONSTRUCTION OF THE COMPLEX UPPER EXTREMITY | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | SAN ANTONIO, TX-20 | 2024 | $1,097,466 |
ASST_NON_HT94252410263_097 PROSTATE-SPECIFIC ANTIANDROGEN THERAPY FOR LOCALIZED PROSTATE CANCER | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | SAN ANTONIO, TX-20 | 2024 | $1,034,071 |
ASST_NON_W81XWH2020024_097 SALVAGE, PRESERVATION, AND ADVANCED RESUSCITATION THROUGH ENDOTHELIAL STABILIZATION (SPARES). THIS MODIFICATION: 1. EXTENDS THE POP BY 12 MONTHS. TECHNICAL AND FINANCIAL REPORTING… | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | SAN ANTONIO, TX-35 | 2025 | $996,388 |
ASST_NON_FA86501926950_097 MESENCHYMAL STEM CELL DERIVED EXOSOMES AS A MODULATOR OF PERIPHERAL NERVE REGENERATION/REPAIR - NO COST TIME EXTENSION | Department of Defense Department of the Air Force | 12.300 BASIC AND APPLIED SCIENTIFIC RESEARCH | — | 2024 | $982,563 |
CONT_AWD_HT942525CE042_9700_-NONE-_-NONE- RESEARCH AND DEVELOPMENT SERVICES FOR THE RESEARCH STUDY TITLED MAPPING TEMPORAL DYNAMICS OF IMMUNE RESPONSES IN SEVERE MULTISYSTEM AND ORTHOPEDIC POLYTRAUMA USING SINGLE-CELL MUL… | Department of Defense Defense Health Agency | — | SAN ANTONIO, TX-28 | 2025 | $935,000 |
ASST_NON_HT94252510987_097 PFAS AND OTHER TOXIC MILITARY EXPOSURES AND PANCREATIC CANCER RISK IN A MILITARY POPULATION | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | SAN ANTONIO, TX-20 | 2025 | $864,533 |
ASST_NON_HU00012520026_097 REMOTE MONITORING OF CARDIOPULMONARY FUNCTION WITH A RUGGED WEARABLE TISSUE OXIMETER | Department of Defense Uniformed Services University of the Health Sciences | 12.750 UNIFORMED SERVICES UNIVERSITY MEDICAL RESEARCH PROJECTS | BETHESDA, MD-08 | 2025 | $847,096 |
ASST_NON_W81XWH1910670_097 NOVEL ANTIMICROBIAL EXTERNAL FIXATION DEVICE TO COMBAT PIN TRACK INFECTION. THIS MODIFICATION:1. EXTENDS THE POP BY 12 MONTHS. TECHNICAL AND FINANCIAL REPORTING SHALL CONTINUE IN… | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | SAN ANTONIO, TX-35 | 2024 | $749,894 |
ASST_NON_W81XWH2010658_097 NANOPARTICULATE SCRUB TO REMOVE BIOFILM BACTERIA FROM THE SKIN/IMPLANT INTERFACE IN OSSEOINTEGRATED IMPLANTS | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | SAN ANTONIO, TX-35 | 2024 | $749,872 |
ASST_NON_W81XWH2220011_097 DEVELOPING WARM, FRESH, WHOLE BLOOD TRANSFUSION SKILLS FOR COMBAT MEDICS | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | SAN ANTONIO, TX-20 | 2024 | $684,631 |
ASST_NON_W81XWH2020067_097 INVESTIGATION OF A NEW CHEMICAL AGENT FOR USE IN COVERAGE PRODUCTS TO TREAT AND PREVENT LARGE SECOND- AND THIRD-DEGREE BURN WOUND INFECTIONS FOR PROLONGED FIELD CARE APPLICATIONS.… | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | SAN ANTONIO, TX-35 | 2024 | $499,783 |
ASST_NON_R21HL152318_075 BISPECIFIC ANTIBODY TO TARGET FVIII-SPECIFIC B CELLS - ABSTRACT: THE ANTIBODY RESPONSE TO FACTOR VIII (FVIII) IN HEMOPHILIA A PATIENTS IS A CRITICAL PROBLEM SINCE THESE ANTIBODIES… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | MD-90 | 2025 | $384,620 |
ASST_NON_W81XWH2020054_097 TREATMENT OF ACUTE BURN WOUNDS FOR IMPROVED CARE AND HEALING DE-OBLIGATE FUNDS TO CLOSE AWARD 1. PER SECTION 711 OF THE NATIONAL DEFENSE AUTHORIZATION ACT (NDAA) 2019, THE US ARMY… | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | SAN ANTONIO, TX-35 | 2025 | $318,959 |
ASST_NON_HT94252510910_097 THERAPEUTIC EFFECTS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA AGONIST ON COMBAT-INDUCED PROLIFERATIVE VITREORETINOPATH | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | SAN ANTONIO, TX-20 | 2025 | $267,544 |
ASST_NON_HT94252310555_097 LOCAL DELIVERY OF BIOENGINEERED MESENCHYMAL STEM CELL-DERIVED EXTRACELLULAR VESICLES FOR TARGETED IMMUNOMODULATION IN VASCULARIZED COMPOSITE ALLOTRANSPLANTATION EXTEND THE PERIOD… | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | SAN ANTONIO, TX-20 | 2025 | $199,973 |
ASST_NON_K23HD118249_075 SINGLE SESSION CBT-INFORMED TREATMENT FOR LOSS OF CONTROL EATING DURING PREGNANCY: A PILOT FEASIBILITY STUDY - ABSTRACT AFFECTING 50% OF PREGNANT WOMEN IN THE US, EXCESS GESTATION… | Department of Health and Human Services National Institutes of Health | 93.865 CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH | MD-90 | 2025 | $161,735 |
ASST_NON_HU00012420086_097 WASTEWATER SURVEILLANCE - WALTER REED NATIONAL MILITARY MEDICAL CENTER ANTIMICROBIAL RESISTANCE PILOT | Department of Defense Uniformed Services University of the Health Sciences | 12.750 UNIFORMED SERVICES UNIVERSITY MEDICAL RESEARCH PROJECTS | BETHESDA, MD-08 | 2024 | $78,476 |
ASST_NON_HU00011920029_097 MILITARY CARDIOVASCULAR OUTCOMES RESEARCH (MICOR). THIS IS AN ADMINISTRATIVE MODIFICATION TO CORRECT BLOCK 7, "PERIOD OF PERFORMANCE END DATE," FROM15 JUN 2025 TO 31 MAR 2025. MOD… | Department of Defense Uniformed Services University of the Health Sciences | 12.750 UNIFORMED SERVICES UNIVERSITY MEDICAL RESEARCH PROJECTS | BETHESDA, MD-08 | 2024 | $0 |
Top 34 awards shown, ranked by obligated amount. Dates reflect performance period; last-modified dates match USAspending.gov. Complete listings include all transaction history going back to FY2024.
Federal Programs (CFDA)
View All→Source: USAspending.gov · All Recipients · Texas